11:04 AM EDT, 09/15/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were higher Monday morning, rising 0.38% to 1,537.74 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and pharmaceutical company Novo Nordisk ( NVO ) , which rose 6.2% and 2.4% respectively. They were followed by internet browser company Opera (OPRA) and lender ING (ING), which were up 1.4% and 1.3% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS (EDAP) and furniture manufacturer Natuzzi (NTZ), which fell 7.3% and 5% respectively. They were followed by software firm SAP (SAP) and 3D printer company Materialise (MTLS), which were down 2.2% and 1.1% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and NuCana ( NCNA ) , which advanced 12% and 4.3% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and lender Lloyds Banking Group ( LYG ) , which increased 3% and 2.2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group ( MREO ) and biotech firm Autolus Therapeutics ( AUTL ) , which dropped 4.3% and 3.6% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and pharmaceutical company AstraZeneca (AZN), which lost 3.1% and 2.3% respectively.